Every November is Pancreatic Cancer Awareness Month. In the United States, approximately 67,000 people are diagnosed with pancreatic cancer each year, representing roughly 3% of new cancer diagnoses. Pancreatic cancer accounts for a disproportionately high share of cancer deaths, at around 8%, underscoring its public-health impact.

Early detection is critical to improving outcomes for many forms of cancer, but there is no recommended screening schedule for pancreatic cancer in average-risk patients. Pancreatic cancer typically causes few or nonspecific symptoms until it is advanced. Because management recommendations and available therapies evolve rapidly, clinicians should regularly consult clinical practice guidelines for the latest evidence-based insights.

Today, we’re taking a look at the most recently published or updated guidelines and consensus statements focused on or related to pancreatic cancer.

Pancreatic Cancer-Related Clinical Guidelines and Statements Published or Updated in 2025

For a look at pancreatic cancer guidelines published prior to 2025, you can view our guidelines rundown from November 2023, which features guidelines from 2015 through 2023. 

Check out other clinical guidelines and sign up for alerts to stay informed on the latest published guidelines and insights.

Copyright © 2025 Guideline Central, all rights reserved.